The chair is currently held by Professor Adrian Hill, who is the principal investigator for the Oxford trial to develop the vaccine
Clinical trials of the indigenous COVID-19 COVAXIN may be delayed further as multiple institutes, which are selected to hold these trials, still evaluating the process.
The Science and Technology ministry edited a press release to remove a sentence that suggested a vaccine against COVID-19 is "unlikely to be ready for mass use before 2021".
The Indian Council of Medical Research has said it aims to complete the indigenous COVID-19 vaccine’s clinical trials as soon as possible, and that it has not set August 15 as a deadline.
The Indian Council of Medical Research and private pharmaceutical company Bharat Biotech India earlier said that they hoped to launch a vaccine against the novel coronavirus for public health use latest by August 15.
Sanofi had said in April that the novel coronavirus vaccine, if successful, would be available in the second half of 2021.
In March, J&J signed deals with the US government to create enough manufacturing capacity to produce more than 1 billion doses of its vaccine through 2021, even before it has evidence that it works.
The new process is likely to help Indian pharmaceutical companies develop and get a COVID-19 vaccine to the market faster.
In this edition of Big Story, Moneycontrol's Sakshi Batra shares details on the progress made on this front.
The London-listed company said it was in talks with governments on backing for the programme, which would effectively allow for a scaling up of production of future successful vaccines
That's surprisingly low considering the effort going into the global race for a vaccine against the coronavirus that has sparked a pandemic since first emerging from China late last year.
The project will compress what is typically 10 years of vaccine development and testing into a matter of months, testimony to the urgency to halt a pandemic that has infected more than 5 million people
"But there will still be a long way to go from there until an approved active substance becomes available in large quantities for the global population." he said
Dozens of researchers across the globe are racing against time to come out with a vaccine for coronavirus that has infected over 53 lakh people and has killed over 3.4 lakh globally.
Serum Institute, the world’s largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.
"Two of the world's frontrunners to develop a vaccine is right here in the UK, at the University of Oxford and Imperial College London." he added.
"There will be no particular advance given to any country," Serge Weinberg told France 2 television.
Trudeau unveiled new measures to support hard hit sectors, including C$470 million ($334 million) for fisheries, and the partial reopening of some national parks.
In his interventions during the second G20 virtual trade and investment ministers meeting, Commerce and Industry Minister Piyush Goyal asked the G20 members to first focus on immediate and concrete actions that can ease the distress being faced by people all over the world due to COVID-19 pandemic.
Over 100 potential COVID-19 vaccines are currently under development, but four are ahead of the pack.
The study, published in the Journal of Molecular Biology, identifies a structural loop in the SARS-CoV-2 spike protein, an area of the virus that facilitates entry into cells.
Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.
Chairing a meeting of the Task Force on Corona Vaccine Development, Drug Discovery, Diagnosis and Testing, he took note of the "extraordinary coming together" of academia, industry and government, combined with speedy but efficient regulatory process.
About 100 research groups are pursuing vaccines with nearly a dozen in early stages of human trials or poised to start.
Sporadic outbreaks of vaccine-preventable diseases, including measles and diphtheria, have already been seen in parts of Bangladesh, Pakistan and Nepal, the UN Children's Fund said.